30-July-2019: The global human milk
oligosaccharides market size is expected to reach USD
71.2 billion by 2025, according to a new report by Grand View Research, Inc.
The human milk oligosaccharide (HMO) market is projected to witness a strong
CAGR of 21.9% during the forecast period. Growing consumer awareness regarding
infant health is expected to be the key factor driving the market. Moreover,
heavy investments by prominent companies in emerging economies is anticipated
to fuel the industry growth. The global infant formula market was valued at
over USD 45.0 billion in 2016, with Asia being the dominant region.
Increasing number
of middle-class households and number of working women are among the key
reasons behind the growth of the infant formula market. Presence of numerous
companies and resultant competition in this sector is likely to facilitate the
usage of HMO in infant formula over the forecast period, boosting the market
growth. High demand for dietary supplements owing to increased health
consciousness is also expected to augment the market growth over the forecast
period. HMOs in dietary supplements provide benefits, such as enhanced immune
system and digestive comfort.
For example, DuPont
Nutrition & Health’s CARE4U is used as a dietary supplement ingredient. The
market witnessing intense competition due to the increasing number of market
entrants. For instance, in June 2018, BASF announced that it will launch its
HMO ingredient 2’FL by early 2019. Similarly, in June 2018, Abbott introduced
its new infant formula product, Similac Eye-Q Plus with HMO, in Vietnam.
In
depth research report on Human Milk Oligosaccharides (HMO) Market
Further key findings from the study suggest:
·
In terms of revenue, the infant formula segment is expected
to witness the fastest CAGR of 22.0% over the forecast period
·
North America accounted for a share of over 80% in 2017, in
terms of revenue on account of early adoption of the product and presence of
numerous infant formula companies in the region
·
Business expansion and product launch are the major
strategies undertaken by major companies in the global HMO market.
·
For instance, in November 2016, Inbiose NV partnered with
DuPont Nutrition & Health and launched a new infant nutrition ingredient,
based on complex carbohydrates found in human milk.
Grand View Research
has segmented the global human milk oligosaccharide market on the basis of
application and region:
HMO Application Outlook (Volume, Kilotons; Revenue, USD
Million, 2014 - 2025)
·
Infant Formula
·
Functional Food & Beverages
·
Food Supplements
·
Others
Browse
more research reports of this category:
About
Grand View Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, the company offers market
intelligence studies ensuring relevant and fact-based research across a range
of industries including technology, chemicals, materials, healthcare and
energy.
